
    
      OBJECTIVES:

        -  Determine whether pomegranate juice can decrease or slow rising prostate-specific
           antigen (PSA) levels in patients who have undergone radical prostatectomy or
           radiotherapy for adenocarcinoma of the prostate.

      OUTLINE: Patients receive oral pomegranate juice once daily. Treatment continues for 18
      months in the absence of disease progression or unacceptable toxicity.

      PROJECTED ACCRUAL: A total of 29-40 patients will be accrued for this study.
    
  